The Truth Behind the Global Chip Shortage
GM and Toyota factories are shutting down...Mass shortages of electronics...Medical device production nearly halted...

And what happens next for investors.
Click Here to See His Urgent Warning.
Bruce C. Cozadd, insider at Jazz Pharmaceuticals
Bruce C. Cozadd Insider Alerts

Get notified the next time Bruce C. Cozadd buys or sells Jazz Pharmaceuticals stock. Enter your email address below to get our daily insider buying and selling report.

Bruce C. Cozadd Insider Information

Bruce C. Cozadd brings extensive experience in research and development, manufacturing and sales and marketing. After being inspired by the culture at ALZA where he started his career, Mr. Cozadd wanted to start a company where top talent can do their best and work inclusively as a team. It was under these ideals that Mr. Cozadd co-founded Jazz Pharmaceuticals Inc. in 2003.

Mr. Cozadd co-founded Jazz Pharmaceuticals, Inc. in 2003 and has served as our Chairman and Chief Executive Officer since April 2009. From 1991 until 2001, he held various positions with ALZA Corporation, a pharmaceutical company acquired by Johnson & Johnson, most recently as Executive Vice President and Chief Operating Officer, with responsibility for research and development, manufacturing and sales and marketing. Previously at ALZA Corporation he held the roles of Chief Financial Officer and Vice President, Corporate Planning and Analysis. Mr. Cozadd serves on the board of Biotechnology Innovation Organization (BIO), a biotechnology trade association, where he serves on its Health Section Governing Board. Mr. Cozadd also serves on the boards of two non-profit organizations, The Nueva School and SFJAZZ. He received a B.S. from Yale University with a double major in molecular biophysics and biochemistry and economics and an M.B.A. from the Stanford Graduate School of Business.

What is Bruce C. Cozadd's net worth?

The estimated net worth of Bruce C. Cozadd is at least $42.77 million as of August 2nd, 2021. Mr. Cozadd owns 307,388 shares of Jazz Pharmaceuticals stock worth more than $42,766,892 as of January 20th. This net worth evaluation does not reflect any other assets that Mr. Cozadd may own. Learn More.

How do I contact Bruce C. Cozadd?

The corporate mailing address for Mr. Cozadd and other Jazz Pharmaceuticals executives is FIFTH FLOOR WATERLOO EXCHANGE WATERLOO ROAD, DUBLIN L2, D04. Jazz Pharmaceuticals can also be reached via phone at (531) 634-7800 and via email at [email protected]

Has Bruce C. Cozadd been buying or selling shares of Jazz Pharmaceuticals?

Bruce C. Cozadd has not been actively trading shares of Jazz Pharmaceuticals during the last ninety days. Most recently, Bruce C. Cozadd sold 6,748 shares of the business's stock in a transaction on Wednesday, December 1st. The shares were sold at an average price of $122.66, for a transaction totalling $827,709.68.

Who are Jazz Pharmaceuticals' active insiders?

Jazz Pharmaceuticals' insider roster includes Patricia Carr (SVP), Bruce Cozadd (CEO), Finbar Larkin (SVP), and Elmar Schnee (Director).

Are insiders buying or selling shares of Jazz Pharmaceuticals?

During the last year, Jazz Pharmaceuticals insiders bought shares 1 times. They purchased a total of 1,500,000 shares worth more than $33,000,000.00. During the last year, insiders at the specialty pharmaceutical company sold shares 16 times. They sold a total of 44,466 shares worth more than $6,684,477.00. The most recent insider tranaction occured on December, 2nd when Director Mark Douglas Smith sold 417 shares worth more than $50,582.10. Insiders at Jazz Pharmaceuticals own 4.3 % of the company.

Information on this page was last updated on 12/2/2021.

Bruce C. Cozadd Insider Trading History at Jazz Pharmaceuticals

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/1/2021Sell6,748$122.66$827,709.68View SEC Filing Icon  
11/1/2021Sell6,556$134.75$883,421.00View SEC Filing Icon  
10/4/2021Sell6,598$129.87$856,882.26View SEC Filing Icon  
8/2/2021Sell1,750$169.98$297,465.00307,388View SEC Filing Icon  
5/5/2021Sell500$170.00$85,000.00321,841View SEC Filing Icon  
5/3/2021Sell1,500$164.24$246,360.00321,841View SEC Filing Icon  
4/1/2021Sell1,500$164.96$247,440.00323,341View SEC Filing Icon  
1/4/2021Sell7,950$162.01$1,287,979.50319,532View SEC Filing Icon  
11/2/2020Sell1,000$145.13$145,130.00331,180View SEC Filing Icon  
10/1/2020Sell4,500$141.94$638,730.00332,180View SEC Filing Icon  
9/1/2020Sell500$134.90$67,450.00336,680View SEC Filing Icon  
1/2/2020Sell1,250$149.61$187,012.50300,138View SEC Filing Icon  
11/5/2019Sell500$130.00$65,000.00311,855View SEC Filing Icon  
11/1/2018Sell1,300$159.45$207,285.00278,615View SEC Filing Icon  
10/1/2018Sell1,300$167.99$218,387.00279,915View SEC Filing Icon  
9/21/2018Sell1,300$164.36$213,668.00281,215View SEC Filing Icon  
8/1/2018Sell1,600$173.90$278,240.00282,515View SEC Filing Icon  
7/2/2018Sell1,600$170.81$273,296.00284,115View SEC Filing Icon  
5/1/2018Sell1,000$151.57$151,570.00View SEC Filing Icon  
4/2/2018Sell1,000$150.01$150,010.00293,542View SEC Filing Icon  
3/9/2018Sell1,000$150.00$150,000.00294,542View SEC Filing Icon  
2/28/2018Sell1,000$150.00$150,000.00267,468View SEC Filing Icon  
10/2/2017Sell1,000$150.00$150,000.00View SEC Filing Icon  
5/11/2017Sell30,000$153.47$4,604,100.00296,418View SEC Filing Icon  
4/11/2017Sell1,000$152.12$152,120.00308,491View SEC Filing Icon  
3/8/2016Sell2,500$126.04$315,100.00302,566View SEC Filing Icon  
2/9/2016Sell2,500$111.37$278,425.00281,896View SEC Filing Icon  
1/12/2016Sell2,500$123.81$309,525.00284,396View SEC Filing Icon  
12/8/2015Sell2,500$139.72$349,300.00286,855View SEC Filing Icon  
11/10/2015Sell2,500$128.53$321,325.00289,355View SEC Filing Icon  
10/13/2015Sell2,500$131.50$328,750.00291,855View SEC Filing Icon  
7/14/2015Sell5,000$177.79$888,950.00View SEC Filing Icon  
6/9/2015Sell5,000$173.16$865,800.00View SEC Filing Icon  
4/14/2015Sell5,000$181.45$907,250.00View SEC Filing Icon  
12/9/2014Sell5,000$178.79$893,950.00View SEC Filing Icon  
9/9/2014Sell5,000$170.32$851,600.00View SEC Filing Icon  
8/12/2014Sell5,000$133.15$665,750.00View SEC Filing Icon  
7/8/2014Sell5,000$155.00$775,000.00View SEC Filing Icon  
6/10/2014Sell5,000$142.34$711,700.00View SEC Filing Icon  
See Full Table

Bruce C. Cozadd Buying and Selling Activity at Jazz Pharmaceuticals

This chart shows Bruce C Cozadd's buying and selling at Jazz Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Jazz Pharmaceuticals Company Overview

Jazz Pharmaceuticals logo
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: Xyrem, Xywav, Sunosi, Erwinaze, Vyxeos, Defitelio, and Zepzelca. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $139.13
Low: $138.95
High: $144.48

50 Day Range

MA: $130.55
Low: $119.87
High: $149.74

2 Week Range

Now: $139.13
Low: $117.64
High: $189.00


502,516 shs

Average Volume

783,762 shs

Market Capitalization

$8.55 billion

P/E Ratio


Dividend Yield



Apple Could Be Days Away From Shocking The World
The "Black Box" Device Bringing the Age of the Smartphone to an End.
Learn More